🛡️Immune SupportIntermediate

Thymosin Alpha-1 Immune Protocol

Last updated:

Immune modulating peptide for chronic illness, immune deficiency, and infection recovery.

Duration

Minimum 3 months

Frequency

2-3 times weekly

Peptides

1 peptide

Goal

Immune Support

Peptides in Protocol

Overview

Immune modulating peptide for chronic illness, immune deficiency, and infection recovery.

Peptides Involved

Compare the peptides included in this protocol side by side.

Typical Dose
Thymosin Alpha-1Approved🛡️Immune Support3,108.27 Da1.6 mg 2-3 times weekly for immune support; daily for 7-14 days for acute

Comparing 1 peptide

Dosage Schedule

Dosage

1.6mg subcutaneous

Frequency

2-3 times weekly

Cycle Information

Minimum 3 months

Minimum 3-month trials for chronic conditions. Repeat immune panels at 3 months to assess response.

Stacking Notes

Can combine with LL-37 for enhanced antimicrobial effects. Zinc (30mg daily) and Vitamin D (5000 IU) recommended.

Warnings & Precautions

Requires sustained use. Monitor immune markers.

Research Use Only. This information is for educational and research purposes only. Not intended for medical advice or self-medication.

Frequently Asked Questions

Immune modulating peptide for chronic illness, immune deficiency, and infection recovery.

1.6mg subcutaneous

2-3 times weekly

Minimum 3 months

Requires sustained use. Monitor immune markers.

Dosage Calculator
Calculate reconstitution volumes and injection amounts for your protocol.
Browse More Protocols
Explore other immune support protocols and find the right one for your research.